13F Holdings
中文EN

PAVM PAVmed Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1624326 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY410.3%
TTM net income YoY-693.3%
TTM EPS YoY—
Revenue 3-yr CAGR-54.7%
Net income 3-yr CAGR—

Margins

Gross margin-212.2%
Operating margin-19,315.5%
Net margin-12,406.8%
FCF margin-3,024.3%
EBITDA margin-19,264.2%

Returns

ROE-61.2%
ROA-50.1%
ROIC (approx.)-84.8%
Asset turnover0.00x

Leverage & solvency

Liabilities / assets71.2%
Debt / equity0.00x
Current ratio0.41x
Interest coverage-5,717.40x

Cash quality & payout

Operating cash flow / net income0.24x
Accruals ratio-38.1%
Payout ratio—
Capex / revenue38.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$71,000$3.00M$2.45M$377,000$500,000
Cost of revenue$218,000$4.84M$6.42M$3.61M$585,000
Gross profit-$147,000-$1.84M-$3.97M-$3.24M-$85,000
R&D expense$4.49M$5.93M$14.28M$25.34M$19.85M
SG&A expense$16.25M$24.52M$30.95M$41.41M$25.42M
Operating income-$21.81M-$44.49M-$68.80M-$91.09M-$54.39M
Interest expense$21,000$45,000$589,000$1.28M—
Pretax income-$2.47M$28.43M-$79.26M-$103.24M-$56.13M
Income tax$0$0———
Net income$401,000$39.79M-$64.17M-$88.98M-$50.35M
EBITDA-$21.70M-$43.29M-$65.86M-$88.63M-$54.17M
EPS (basic)-5.6399.15-9.16-15.03-0.65
EPS (diluted)-5.6314.90-9.16-15.03-0.65
Weighted avg. shares (diluted)670,4662.17M7.23M5.94M77.52M
Balance sheet
Cash & equivalents$1.24M$1.19M$19.64M$39.74M$77.26M
Receivables$15,000$18,000$61,000$17,000$200,000
Inventory——$278,000$111,000—
Current assets$2.26M$2.16M$24.50M$43.93M$82.64M
PP&E, net$77,000$151,000$1.78M$2.45M$1.58M
Intangibles——$1.42M$3.44M$2.03M
Total assets$38.81M$30.66M$33.12M$53.98M$86.98M
Current liabilities$14.84M$35.45M$54.18M$41.20M$7.56M
Total liabilities$16.51M$37.69M$57.14M$43.05M$7.56M
Shareholders' equity$33.97M-$2.50M-$53.83M-$9.68M$61.67M
Shares outstanding927,934373,3008.58M6.30M86.37M
Cash flow statement
Operating cash flow-$5.21M-$33.55M-$52.04M-$70.98M-$40.59M
Capital expenditure$31,000$55,000$242,000$1.54M$1.47M
Free cash flow-$5.24M-$33.61M-$52.28M-$72.53M-$42.06M
Investing cash flow-$31,000-$16.18M$758,000-$4.74M-$3.72M
Financing cash flow$5.59M$31.28M$31.17M$38.21M$104.31M
Depreciation & amortization$105,000$1.20M$2.93M$2.46M$226,000
Stock-based compensation$1.71M$6.45M$11.14M$19.53M$15.01M

Free plan shows the latest 5 periods; Pro shows all 11 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.